Bausch Health Americas, Inc.
Clinical trials sponsored by Bausch Health Americas, Inc., explained in plain language.
-
New foam treatment could ease colitis in kids
Disease control Not yet recruitingThis study tests a steroid foam (budesonide) given rectally to children aged 5 to 17 with mild to moderate distal ulcerative colitis. The goal is to see if it can safely induce remission by reducing inflammation, bleeding, and stool frequency. About 100 children will receive eith…
Phase: PHASE4 • Sponsor: Bausch Health Americas, Inc. • Aim: Disease control
Last updated Jun 12, 2026 12:05 UTC
-
New acne gel study for kids: could this be the answer to stubborn pimples?
Symptom relief Not yet recruitingThis study tests a prescription gel called CABTREO in children aged 9 to 11 with moderate to severe acne. The gel combines three medicines to fight bacteria, unclog pores, and reduce inflammation. Researchers will check for side effects and measure how much acne improves over 12 …
Phase: PHASE4 • Sponsor: Bausch Health Americas, Inc. • Aim: Symptom relief
Last updated Jun 15, 2026 19:02 UTC
-
New hope for depressed youth? drug trial targets teen blues
Symptom relief Not yet recruitingThis study tests whether the drug bupropion can safely reduce depression symptoms in children and teenagers aged 7 to 17 with major depressive disorder. About 246 participants will receive either the drug or a placebo. The main goal is to see if their depression scores improve by…
Phase: PHASE4 • Sponsor: Bausch Health Americas, Inc. • Aim: Symptom relief
Last updated Jun 08, 2026 13:10 UTC